MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stem cell method may cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare donor stem cells for transplant in people with blood cancers like leukemia. By removing certain immune cells from the donated cells, researchers hope to lower the risk of graft-versus-host disease, a serious side effect. The study involves 70…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
New drug cocktail aims to prevent deadly transplant complication
Disease control Recruiting nowThis study tests a new combination of three drugs (cyclophosphamide, tacrolimus, and ruxolitinib) to prevent graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers like leukemia. The goal is to see if this approach can reduce severe GVHD and…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New study tests if antibody blood test can spot autoimmune platelet disorder
Knowledge-focused Recruiting nowThis study is testing whether a special blood test (MAIPA) can help doctors tell if a low platelet count is caused by an autoimmune problem. It will include 225 adults with low platelets who haven't started treatment yet. The goal is to see if the test can make diagnosis faster a…
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 26, 2026 07:09 UTC